Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download PDF
Document related concepts
Transcript
Correction Correction: Mutations in UBA3 Confer Resistance to the NEDD8-Activating Enzyme Inhibitor MLN4924 in Human Leukemic Cells The PLOS ONE Staff Dr. Bruno Medeiros is not included in the author byline. He should be listed as the eleventh author and affiliated with Division of Hematology, Stanford University School of Medicine, Stanford, CA, USA. The contributions of this author are as follows: Conceived and designed the experiments, performed the experiments, and analyzed the data. Reference 1. Xu GW, Toth JI, da Silva SR, Paiva S-L, Lukkarila JL, et al. (2014) Mutations in UBA3 Confer Resistance to the NEDD8-Activating Enzyme Inhibitor MLN4924 in Human Leukemic Cells. PLoS ONE 9(4): e93530. doi:10.1371/ journal.pone.0093530 Citation: The PLOS ONE Staff (2014) Correction: Mutations in UBA3 Confer Resistance to the NEDD8-Activating Enzyme Inhibitor MLN4924 in Human Leukemic Cells. PLoS ONE 9(10): e112004. doi:10.1371/journal.pone.0112004 Published October 22, 2014 Copyright: ß 2014 The PLOS ONE Staff. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. PLOS ONE | www.plosone.org 1 October 2014 | Volume 9 | Issue 10 | e112004
